2015
DOI: 10.1016/j.medmal.2015.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Three years of antibiotic consumption evaluation in French nursing homes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 7 publications
1
6
2
Order By: Relevance
“…Co-amoxiclav and fluoroquinolones are broad-spectrum antibiotics which have been linked to side-effects including Clostridium difficile infections and antimicrobial resistance [ 22 - 24 ]. The same pattern of co-amoxiclav followed by fluoroquinolones as the most commonly prescribed antibiotics was found in a French study [ 10 ]. In the HALT and HALT-2 studies, most patients received penicillins variously co-prescribed with co-amoxiclav, other antibacterials (J01X, mostly nitrofurantoin) and fluoroquinolones.…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…Co-amoxiclav and fluoroquinolones are broad-spectrum antibiotics which have been linked to side-effects including Clostridium difficile infections and antimicrobial resistance [ 22 - 24 ]. The same pattern of co-amoxiclav followed by fluoroquinolones as the most commonly prescribed antibiotics was found in a French study [ 10 ]. In the HALT and HALT-2 studies, most patients received penicillins variously co-prescribed with co-amoxiclav, other antibacterials (J01X, mostly nitrofurantoin) and fluoroquinolones.…”
Section: Discussionsupporting
confidence: 75%
“…The first step towards improved antimicrobial prescribing is to analyse the current patterns of antimicrobial use. Several studies on antimicrobial use in LTCFs have been published in the past few years, but with some exceptions [ 6 - 10 ], the studies included relatively few LTCFs from one country. Slovenia was included in the Healthcare-Associated Infections in Long-Term Care Facilities Project (HALT) in 2010 with six LTCFs and in the 2013 HALT-2 study with four LTCFs; in the latter study the Slovenian LTCF sample was not representative [ 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…14,21,22 Results from the present study suggest that the antibacterial use and variability in the LTCFs of the canton of Vaud are similar to those observed in other European and North American LTCFs. The aggregate antibacterial use rates in LTCFs of the canton of Vaud in 2016 were lower than those reported by Marquet et al for 74 French LTCFs, which had a total antibacterial use of 44.8 DDD per 1000 patient-days in 2013, 23 but were higher than those reported in studies from Nordic European countries. 24,25 Indeed, a cross-sectional descriptive study by Blix et al showed a median of 14.8 DDD/100 bed-days in 133 Norwegian LTCFs.…”
Section: Discussioncontrasting
confidence: 59%
“…Fourteen studies reported a range from 2.1 to 13.0 antibiotic courses per 1000 resident days [ 8 , 30 , 40 , 56 , 70 , 73 , 80 , 90 , 93 , 95 , 107 , 109 , 111 , 112 ]. Finally, 15 studies reported a range of 38.2 to 148 DDD/1000 bed days [ 8 , 41 , 53 , 55 , 67 , 74 , 79 , 82 84 , 88 , 89 , 92 , 102 , 106 ]. Details are provided in S8 File .…”
Section: Resultsmentioning
confidence: 99%
“…As a result of this national regulation, quinolone use in Australian LTCFs is low, despite overall antibiotic use in Australian LTCFs being high compared to other regions. A positive finding with respect to antibiotics on the WHO Watch List was that macrolides were reported to be among the three most frequently prescribed antibiotics in only four studies, one from France [ 74 ], one from the US [ 40 ], and two from Japan [ 67 , 100 ].…”
Section: Discussionmentioning
confidence: 99%